View in EDS

Real World Outcomes for the Efficacy and Safety of Osimertinib in Black Patients With Nonsmall Cell Lung Cancer.

Saved in:
Bibliographic Details
Title: Real World Outcomes for the Efficacy and Safety of Osimertinib in Black Patients With Nonsmall Cell Lung Cancer.
Authors: Kilpatrick M; Department of Pharmaceutical Services, Emory University Hospital Midtown/Winship Cancer Institute, Atlanta, GA. Electronic address: mattie.kilpatrick@emoryhealthcare.org., Gundersen P; Department of Pharmaceutical Services, Intermountain Health, Salt Lake City, UT., O'Reilly K; Department of Pharmaceutical Services, Emory University Hospital Midtown/Winship Cancer Institute, Atlanta, GA., Goyal S; Biostatistican Department, Winship Cancer Institute/Emory University, Atlanta, GA., Sun L; Department of Pharmacy, Cedars-Sinai Medical Center, Los Angeles, CA., Kim P; Medical Affairs, Amgen Inc, Thousand Oaks, CA., Carlisle J; Department of Hematology/Oncology, Emory School of Medicine, Winship Cancer Institute, Atlanta, GA.
Source: Clinical lung cancer [Clin Lung Cancer] 2026 Jul; Vol. 27 (6), pp. 11-18. Date of Electronic Publication: 2026 May 05.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 100893225 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0690 (Electronic) Linking ISSN: 15257304 NLM ISO Abbreviation: Clin Lung Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42218097
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Real World Outcomes for the Efficacy and Safety of Osimertinib in Black Patients With Nonsmall Cell Lung Cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kilpatrick+M%22">Kilpatrick M</searchLink>; Department of Pharmaceutical Services, Emory University Hospital Midtown/Winship Cancer Institute, Atlanta, GA. Electronic address: mattie.kilpatrick@emoryhealthcare.org.<br /><searchLink fieldCode="AU" term="%22Gundersen+P%22">Gundersen P</searchLink>; Department of Pharmaceutical Services, Intermountain Health, Salt Lake City, UT.<br /><searchLink fieldCode="AU" term="%22O'Reilly+K%22">O'Reilly K</searchLink>; Department of Pharmaceutical Services, Emory University Hospital Midtown/Winship Cancer Institute, Atlanta, GA.<br /><searchLink fieldCode="AU" term="%22Goyal+S%22">Goyal S</searchLink>; Biostatistican Department, Winship Cancer Institute/Emory University, Atlanta, GA.<br /><searchLink fieldCode="AU" term="%22Sun+L%22">Sun L</searchLink>; Department of Pharmacy, Cedars-Sinai Medical Center, Los Angeles, CA.<br /><searchLink fieldCode="AU" term="%22Kim+P%22">Kim P</searchLink>; Medical Affairs, Amgen Inc, Thousand Oaks, CA.<br /><searchLink fieldCode="AU" term="%22Carlisle+J%22">Carlisle J</searchLink>; Department of Hematology/Oncology, Emory School of Medicine, Winship Cancer Institute, Atlanta, GA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100893225%22">Clinical lung cancer</searchLink> [Clin Lung Cancer] 2026 Jul; Vol. 27 (6), pp. 11-18. <i>Date of Electronic Publication: </i>2026 May 05.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>100893225 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1938-0690 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215257304%22">15257304 </searchLink><i>NLM ISO Abbreviation: </i>Clin Lung Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42218097
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.cllc.2026.05.001
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 11
    Titles:
      – TitleFull: Real World Outcomes for the Efficacy and Safety of Osimertinib in Black Patients With Nonsmall Cell Lung Cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kilpatrick M
      – PersonEntity:
          Name:
            NameFull: Gundersen P
      – PersonEntity:
          Name:
            NameFull: O'Reilly K
      – PersonEntity:
          Name:
            NameFull: Goyal S
      – PersonEntity:
          Name:
            NameFull: Sun L
      – PersonEntity:
          Name:
            NameFull: Kim P
      – PersonEntity:
          Name:
            NameFull: Carlisle J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2026 Jul
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1938-0690
          Numbering:
            – Type: volume
              Value: 27
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Clinical lung cancer
              Type: main
ResultId 1